Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Polskie Archiwum Medycyny Wewnetrznej|July 26, 2003
[Results of bone scintigraphy, densitometry and radiography in secondary hyperparathyroidism in patients with chronic renal failure]Jerzy Kosowicz, Paweł Bolko, Andrzej Swiderski
Polskie Archiwum Medycyny Wewnetrznej|July 26, 2003
A rare coexistence of primary hyperparathyroidism and hyperthyroidism due to toxic nodular goiter--a case reportPaweł Bolko, Magdalena Jaskuła, Ryszard Waśko, et al.
Polskie Archiwum Medycyny Wewnetrznej|February 11, 2004
The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma typePaweł Bolko, Magdalena Jaskuła, Ryszard Waśko, et al.
Pharmacy World & Science : PWS|February 3, 2005
The efficacy of octreotide LAR (long acting release) treatment in patients with somatotropinoma, and mixed pituitary tumoursRyszard Waśko, Paweł Bolko, Maciej Owecki, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 10, 2002
[Is hyperthyroidism often present in patients with thyroid differentiated carcinoma?]Paweł Bolko, Katarzyna Łacka, Ewa Manuszewska, et al.
Endokrynologia Polska|January 27, 2007
[Lymphocytic hypophysitis and hypothalamitis-case report]Maria Stelmachowska, Paweł Bolko, Ryszard Waśko, et al.
Archivum Immunologiae Et Therapiae Experimentalis|December 25, 2003
Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinomaPaweł Bolko, Ewa Manuszewska-Jopek, Krzysztof Michałek, et al.
Contemporary Oncology (Poznan, Poland)|March 6, 2014
Assessment of real-world usage of lanreotide AUTOGEL 120 in Polish acromegalic patients - results from the prospective 12-month phase of Lanro-StudyEwa Orlewska, Beata Kos-Kudła, Jerzy Sowiński, et al.
Pageof 1